Newsbenzinga
Europe Approves Sanofi's Multiple Sclerosis Drug Despite FDA Rejection
· Published
Article summary
Sanofi won European approval for Cenrifki in SPMS and secured Japan authorization for Wayrilz in chronic ITP.
An excerpt from the original article.
Comments —
Loading comments…